ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,512Medicare Part D Prescriptions Filled, Including Refills

Rank: 56 out of 1155

$528K Total Retail Price of All Prescriptions

Rank: 41 out of 1155

454 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
44% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oregon
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 454 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

15% of this provider’s 454 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

3% of this provider’s 6,978 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oregon
OMEPRAZOLE 479 372 1 5
SIMVASTATIN 360 297 2 3
LISINOPRIL 342 283 3 1
HYDROCODONE-ACETAMINOPHEN 339 201 S3 4 4
AMLODIPINE BESYLATE 337 310 5 6
ATENOLOL 325 261 6 10
METFORMIN HCL 259 181 7 7
LEVOTHYROXINE SODIUM 252 194 8 2
FUROSEMIDE 242 230 9 8
ATORVASTATIN CALCIUM 233 171 10 12
CITALOPRAM HBR 217 184 11 19
HYDROCHLOROTHIAZIDE 191 161 12 9
CYMBALTA 131 82 13 46
POTASSIUM CHLORIDE 128 115 14 16
ZOLPIDEM TARTRATE 125 91 15 21
GABAPENTIN 124 67 16 15
PRAVASTATIN SODIUM 119 74 17 20
LOSARTAN POTASSIUM 111 110 18 18
PROAIR HFA 104 60 19 31
TRAMADOL HCL 96 59 20 32
AMITRIPTYLINE HCL 95 44 R 21 42
OXYCODONE HCL 94 46 S2 22 23
FLUOXETINE HCL 79 30 23 30
NAMENDA 77 77 24 67
METOPROLOL SUCCINATE 75 59 25 17
POLYETHYLENE GLYCOL 3350 70 40 26 59
PREMARIN 66 52 R 27 110
IBUPROFEN 65 25 28 63
TRAZODONE HCL 65 39 28 22
CELEBREX 61 43 30 132
PROMETHAZINE HCL 58 16 R 31 105
VENLAFAXINE HCL ER 57 18 32 68
LAMOTRIGINE 57 28 32 133
ROPINIROLE HCL 56 43 34 94
PROPRANOLOL HCL 54 39 35 97
CYCLOBENZAPRINE HCL 54 23 R 35 38
ADVAIR DISKUS 53 53 37 35
WARFARIN SODIUM 53 53 37 11
OXYCODONE-ACETAMINOPHEN 52 27 S2 39 45
KLOR-CON 10 52 52 39 108
DONEPEZIL HCL 52 39 39 41
METOPROLOL TARTRATE 50 43 42 14
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 27, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.